Format

Send to

Choose Destination
Gene. 2013 May 10;520(1):1-6. doi: 10.1016/j.gene.2013.02.037. Epub 2013 Mar 5.

How induced pluripotent stem cells are redefining personalized medicine.

Author information

1
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, United States. leonardoferreira@fas.harvard.edu

Abstract

Since the generation of the first induced pluripotent stem (iPS) cells, the stem cell field has grown at an unparalleled pace. Today, these cells have become the major tools in the advancement of personalized medicine. Here we review the experiments that lead to their discovery as well as the latest developments in iPS cell biology. By emphasizing the current applications and limitations of induced pluripotency, we discuss how iPS cells are shaping innovation in personalized therapies. In addition, we analyze the major landmarks in direct lineage reprogramming, a potentially faster alternative to the use of iPS cells in therapy. Finally, we present the current progress in disease modeling and future directions of the treatment of genetic disorders.

PMID:
23470844
DOI:
10.1016/j.gene.2013.02.037
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center